HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ZEIDLER, R. Articles by WOLLENBERG, B. Search for Related Content PubMed PubMed Citation Articles by ZEIDLER, R. Articles by WOLLENBERG, B.

Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1

Department of Otolaryngology, University of Munich, 81377 Munich, Germany

¹Correspondence: Department of Otolaryngology, University of Munich, Marchioninistr. 15, 81377 Munich, Germany. E-mail: rzeidler{at}hno.med.uni-muenchen.de

The cyclooxygenases (COX)-1 and COX-2 are key enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. Whereas COX-1 is expressed ubiquitously, COX-2 is an immediate-early gene often associated with malignant transformation, and a role for the COX enzymes in tumor initiation and promotion is discussed. Nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin and indomethacin that block COX-1 and -2 have been shown to have beneficial effects for tumor patients. Therefore, these compounds have gained interest also among oncologists. However, the molecular mechanism by which NSAIDs inhibit carcinogenesis is not clearly understood. The prostaglandin-dependent and -independent effect may both account for their antineoplastic action. We show here that tumor cells derived from different tumors regularly produce prostaglandin E₂ (PGE₂) interfering with the function of monocytes. In particular, PGE₂ inhibits the potential of monocytes to migrate in the direction of a chemotactic stimulus and to adhere to endothelial cell. This inhibition is most probably due to a modulation of the chemokine receptor CCR5 and the ß2-integrin Mac-1. Both down-regulation of CCR5 and reduced expression of Mac-1 may diminish the potential of peripheral blood monocytes to leave blood vessels and invade target tissues. Since both dysfunctions can be restored with NSAIDs, our findings help to explain the molecular chemopreventive action of NSAIDs on tumor formation and progression.—Zeidler, R., Csanady, M., Gires, O., Lang, S., Schmitt, B., Wollenberg, B. Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1.

Key Words: immune evasion • prostaglandins • migration • adhesion

This article has been cited by other articles:

				M. Profita, A. Sala, A. Bonanno, L. Siena, M. Ferraro, R. Di Giorgi, A. M. Montalbano, G. D. Albano, R. Gagliardo, and M. Gjomarkaj Cysteinyl Leukotriene-1 Receptor Activation in a Human Bronchial Epithelial Cell Line Leads to Signal Transducer and Activator of Transcription 1-Mediated Eosinophil Adhesion J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 1024 - 1030. [Abstract] [Full Text] [PDF]

				C. Bergmann, L. Strauss, R. Zeidler, S. Lang, and T. L. Whiteside Expansion of Human T Regulatory Type 1 Cells in the Microenvironment of Cyclooxygenase 2 Overexpressing Head and Neck Squamous Cell Carcinoma Cancer Res., September 15, 2007; 67(18): 8865 - 8873. [Abstract] [Full Text] [PDF]

				M. J. Lorenowicz, J. van Gils, M. de Boer, P. L. Hordijk, and M. Fernandez-Borja Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis J. Leukoc. Biol., December 1, 2006; 80(6): 1542 - 1552. [Abstract] [Full Text] [PDF]

				G. P. Smyth, P. P. Stapleton, C. B. Barden, J. R. Mestre, T. A. Freeman, M. D. Duff, S. Maddali, Z. Yan, and J. M. Daly Renal Cell Carcinoma Induces Prostaglandin E2 and T-Helper Type 2 Cytokine Production in Peripheral Blood Mononuclear Cells Ann. Surg. Oncol., May 1, 2003; 10(4): 455 - 462. [Abstract] [Full Text] [PDF]

				E. Scandella, Y. Men, S. Gillessen, R. Forster, and M. Groettrup Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells Blood, July 30, 2002; 100(4): 1354 - 1361. [Abstract] [Full Text] [PDF]

				I. Kurth, K. Willimann, P. Schaerli, T. Hunziker, I. Clark-Lewis, and B. Moser Monocyte Selectivity and Tissue Localization Suggests a Role for Breast and Kidney-expressed Chemokine (BRAK) in Macrophage Development J. Exp. Med., September 17, 2001; 194(6): 855 - 862. [Abstract] [Full Text] [PDF]